Exin Therapeutics vs Veeva Systems

Side-by-side comparison of AI visibility scores, market position, and capabilities

Veeva Systems leads in AI visibility (86 vs 36)
Exin Therapeutics logo

Exin Therapeutics

EmergingHealthcare

General

SF AI neurotherapeutics discovery platform for epilepsy/autism/Parkinson's with multimodal neural AI; animal lab + proof-of-concept + 2 patents in 1.5 months; $25M Philippines lab investment competing with Recursion for AI-driven CNS gene therapy.

AI VisibilityBeta
Overall Score
D36
Category Rank
#505 of 596
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
32
Perplexity
37
Gemini
34

About

Exin Therapeutics is a San Francisco-based AI-powered neurotherapeutics drug discovery company — pioneering genetic therapies that target neural activity to treat epilepsy, autism spectrum disorder symptoms, Parkinson's disease, and other neurological conditions using a multimodal AI platform that predicts therapeutic candidate potential across multiple neural disorders simultaneously. Using neural activity recordings, behavioral assays, and transcriptomics data as inputs, Exin's AI models identify genetic intervention targets and predict therapeutic outcomes before entering animal studies — compressing the target identification timeline that traditional neuroscience drug discovery requires. The company established an animal research facility, obtained proof-of-concept results in mice, and filed two provisional patents within 1.5 months of San Francisco operations, and is investing approximately $25 million to build the Philippines' first neurotherapeutics laboratory.

Full profile
Veeva Systems logo

Veeva Systems

LeaderHealthcare Tech

Life Sciences Cloud

Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.

AI VisibilityBeta
Overall Score
A86
Category Rank
#9 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
88
Gemini
90

About

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.

Full profile

AI Visibility Head-to-Head

36
Overall Score
86
#505
Category Rank
#9
84
AI Consensus
78
stable
Trend
stable
32
ChatGPT
84
37
Perplexity
88
34
Gemini
90
33
Claude
92
30
Grok
84

Key Details

Category
General
Life Sciences Cloud
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Veeva Systems
Life Sciences Cloud

Integrations

Only Veeva Systems
Veeva Systems is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.